NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/14/2018
Back to search
Official data from USPTO
CELLBIOCHEM STEM CELL REPAIR KIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLBIOCHEM STEM CELL REPAIR KIT
ST13
US500000076573604Class
5
Filing
76573604
Registration
3286695
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/14/2018
Trademark type
Word
Nice classes
5
Filing date
01/30/2004
Registration date
08/28/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2018
Last transaction
03/14/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2006-05-00
First use in commerce
2006-05-00
Drawing code
4
Owner type
16
Owner location
Naples, FL
Examiner
RUTLAND, BARBARA
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Immunopath Profile, LLC
Immunopath Profile, Inc.
Immunopath Profile, Inc.
Representatives
MICHAEL F. SNYDER VOLPE & KOENIG PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents for biomolecular therapy
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/14/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/14/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/14/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
02/28/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/28/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/11/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/11/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/11/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
08/28/2013
E815
TEAS SECTION 8 & 15 RECEIVED
08/28/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/09/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
08/28/2007
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/23/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/16/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/23/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2007
ALIE
ASSIGNED TO LIE
05/23/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2007
CNRT
NON-FINAL ACTION MAILED
11/06/2006
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/04/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/15/2006
IUAF
USE AMENDMENT FILED
08/21/2006
EISU
TEAS STATEMENT OF USE RECEIVED
08/21/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/21/2006
PUBO
PUBLISHED FOR OPPOSITION
11/29/2005
NPUB
NOTICE OF PUBLICATION
11/09/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/07/2005
ALIE
ASSIGNED TO LIE
09/23/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/23/2005
CNFR
FINAL REFUSAL MAILED
04/08/2005
CNFR
FINAL REFUSAL WRITTEN
04/07/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
03/15/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/18/2005
CNRT
NON-FINAL ACTION MAILED
09/07/2004
CNRT
NON-FINAL ACTION WRITTEN
09/07/2004
DOCK
ASSIGNED TO EXAMINER
08/22/2004
NWAP
NEW APPLICATION ENTERED
02/19/2004
Continuous trademark protection
Get notified about every new filing that threatens CELLBIOCHEM STEM CELL REPAIR KIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.